|
Study of the Response of Human Small Blood Vessels Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Study of the Response of Human Small Blood Vessels conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Study of the Response of Human Small Blood Vessels Clinical research trials and Study of the Response of Human Small Blood Vessels health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Study of the Response of Human Small Blood Vessels. Study of the Response of Human Small Blood Vessels Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Study of the Response of Human Small Blood Vessels clinical trial. Human subjects often get the best healthcare available for their Study of the Response of Human Small Blood Vessels condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of the Response of Human Small Blood Vessels  Study of the Response of Human Small Blood Vessels
Study of the Response of Human Small Blood Vessels
For Condition: Healthy,Hypercholesterolemia,Hypertension
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: A layer of cells called the endothelium line the walls of blood vessels. These cells produce substances that control the tone of blood vessels and thus control blood flow through the vessel. One of the substances produced involved in the control of blood vessel function is nitric oxide. Nitric oxide (NO) plays a role in the relaxation of blood vessels. Researchers have been interested in the function of the endothelium in patients with high blood pressure (essential hypertension) and patients with high cholesterol (hypercholesterolemia). After conducting studies on the endothelium and nitric oxide, researchers have found that the endothelium is indeed functioning abnormally in patients with high blood pressure and high cholesterol. In addition, researchers have determined that the dysfunction is a result of abnormalities in the nitric oxide (NO) system. In this study researchers plan to investigate the relationship between blood vessel responses in real-life settings versus laboratory settings in normal volunteers, patients with high blood pressure, and patients with high cholesterol.
Details: Over the last ten years, we have been interested in the investigation of endothelial function in patients with essential hypertension and patients with hypercholesterolemia. We have performed intra-arterial infusion of endothelium-dependent and endothelium-independent drugs into the brachial artery with noninvasive measurement of the response of the forearm vasculature by means of strain gauge plethysmography. Those studies have allowed us to: a) demonstrate the presence of endothelial dysfunction in patients with essential hypertension and in patients with hypercholesterolemia; and b) identify an abnormality in the endothelium-derived nitric oxide system that is responsible for endothelial dysfunction in these patients. Further studies to more precisely determine the intracellular processes that mediate this abnormality in endothelial function in these patients are limited by the inherent shortcomings of the in vivo technique. An alternative possibility is the study of human small vessels in vitro; however, the relationship between in vivo and in vitro vascular responses to endothelium-dependent and -independent agonists has not been established. In the present study, we propose to investigate this relationship in normal volunteers, patients with essential hypertension, and patients with hypercholesterolemia.
Eligibility:
Study Type: Interventional, Treatment, Safety
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients (men and nonpregnant women) with systemic hypertension, patients with hypercholesterolemia, and normal volunteers. All blood pressure recordings must be consistently elevated. No renovascular hypertension or other etiologies for elevated blood pressure. No definite evidence of accelerated or malignant hypertension (diastolic pressures above 115 mmHg, with associated encephalopathic changes, papilledema, progressive renal failure, or congestive heart failure), or serious intercurrent illness. Patients in whom withdrawal of antihypertensive medications is considered hazardous are ineligible. Patients in whom the blood pressure remains at normal levels 2 weeks after withdrawal of antihypertensive treatment will be closely monitored until they become hypertensive, at which time they will undergo the study. Patients in whom blood pressure does not increase after 2 months of discontinuation of therapy will be excluded from the study. Patients with coexistent hypertension and hypercholesterolemia are ineligible. Normal volunteers who are not taking any kind of medication are eligible. No history of diabetes, peripheral vascular disease, coagulopathy, or any other disease predisposing to vasculitis or Raynaud's phenomenon. No history of keloid formation. All patients must be capable of giving informed consent for all procedures.
Total Enrollment: 87
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 970098; 97-H-0098
Study Start Date: March 21, 1997
Record last reviewed: January 20, 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001622
Other Healthy Studies:
1. Lifestyle Heart Trial
2. Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
3. Adolescent Blood Pressure Variation and Ventricular Mass
4. Prevention of Hypertension: A Randomized Trial
5. Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Study of the Response of Human Small Blood Vessels
|
|
|
|
|
|
|
|
